-+ 0.00%
-+ 0.00%
-+ 0.00%

Achieve Life Sciences Appoints Andrew Goldberg As CEO

Benzinga·04/16/2026 12:58:41
Listen to the news

Achieve Names Two New Exemplary Healthcare Leaders to its Board of Directors 

New Leadership and Financing, up to $354 Million ($180 Million Upfront and $174 Million Dependent on the Exercise of Milestone Warrants), Strengthen Achieve's Position to Execute Development and Launch of Cytisinicline, if Approved, as the First New Treatment for Nicotine Dependence in Two Decades

SEATTLE and VANCOUVER, British Columbia, April 16, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV) today announced it has appointed Andrew D. Goldberg, MD, as Chief Executive Officer and as a member of the Board of Directors, effective following the closing of Achieve's recently announced financing. Dr. Goldberg is a dual board-certified physician who has spent his career at the intersection of medicine and business, advising, investing in, and governing pharmaceutical companies as they navigate the complexities of commercialization.